Analysis of the microbiota in the diabetic foot ulcers: Is research standardization required?
By:
References
- Adeolu M., Alnajar S., Naushad S., Gupta R.S.: Genome-based phylogeny and taxonomy of the ‘Enterobacteriales’: proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov. Int. J. Syst. Evol. Microbiol., 2016; 66: 5575–5599
- Al Benwan K., Al Mulla A., Rotimi V.O.: A study of the microbiology of diabetic foot infections in teaching hospital in Kuweit. J. Infec. Public Health, 2012; 5: 1–8
- Bendy R.H.Jr., Nuccio P.A., Wolfe E., Collins B., Tamburro C., Glass W., Martin C.M.: Relationship of quantitative wound bacterial counts to healing of decubiti: Effect of topical gentamicin. Antimicrob. Agents Chemother., 1964; 10: 147–155
- Bowler P.G., Duerden B.I., Armstrong D.G.: Wound microbiology and associated approaches to wound management. Clin. Microbiol. Rev., 2001; 14: 244–269
- Citron D.M., Goldstein E.J.C., Merriam C.V., Lipsky B.A., Abramson M.A.: Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J. Clin. Microbiol., 2007; 45: 2819–2828
- Crouzet J., Lavigne J.P., Richard J.L., Sotto A., Nîmes University Hospital Working Group on the Diabetic Foot (GP30): Diabetic foot infection: A critical review of recent randomized clinical trials on antibiotic therapy. Int. J. Infect. Dis., 2011; 15: e601–e610
- Dowd S.E., Wolcott R.D., Sun Y., McKeehan T., Smith E., Rhoads D.: Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS One, 2008; 3: e3326
- Gadepalli R., Dhawan B., Sreenivas V., Kapil A., Ammini A.C., Chaudhry R.: A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care, 2006; 29: 1727–1732
- Gardner S.E., Hillis S.L., Heilmann K., Segre J.A., Grice E.A.: The neuropathic diabetic foot ulcer microbiome is associated with clinical factors. Diabetes, 2013; 62: 923–930
- Geerlings S.E., Hoepelman A.I.: Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol. Med. Micro-biol., 1999; 26: 259–265
- Hadadi A., Omdeh Ghiasi H., Hajiabdolbaghi M., Zandekarimi M., Hamidian R.: Diabetic foot: Infections and outcomes in Iranian admitted patients. Jundishapur J. Microbiol., 2014; 7: e11680
- Hatipoglu M., Mutluoglu M., Turhan V., Uzun G., Lipsky B.A. Sevim E., Demiraslan H., Eryilmazh E., Ozuguz C., Memis A., Ay H., Arda B., Uysal S., Motor V.K., Kader C., et al.: Causative pathogens and antibiotic resistance in diabetic foot infections: A prospective multi-center study. J. Diabetes Complications, 2016; 30: 910–916
- International Best Practice Guidelines: Wound Management in Diabetic Foot Ulcers. Wounds International, 2013. https://www.woundsinternational.com/resources/details/best-practice-guidelines-wound-management-diabetic-foot-ulcers
- Kandemir O., Akbay E., Sahin E., Milcan A., Gen R.: Risk factors for infection of the diabetic foot with multi-antibiotic resistant microorganisms. J. Infect. 2007; 54: 439–445
- Khan D.M., Moosabba M.S., Rao I.V.: Prevalence of diabetic foot ulcer infections associated with Gram negative bacteria with special reference to drug resistant isolates. Int. J. Biomed. Res., 2016; 7: 765–770
- Lipsky B.A., Berendt A.R., Cornia P.B., Pile J.C., Peters E.J., Armstrong D.G., Deery H.G., Embil J.M., Joseph W.S., Karchmer A.W., Pinzur M.S., Senneville E., Infectious Diseases Society of America: 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin. Infect. Dis., 2012; 54: e132–e173
- Lipsky B.A., Berendt A.R., Deery H.G., Embil J.M., Joseph W.S., Karchmer A.W., LeFrock J.L., Lew D.P., Mader J.T., Norden C., Tan J.S., Infectious Diseases Society of America: Diagnosis and treatment of diabetic foot infections. Clin. Infect. Dis., 2004, 39: 885–910
- Lipsky B.A., Senneville É., Abbas Z.G., Aragón-Sánchez J., Diggle M., Embil J.M., Kono S., Lavery L.A., Malone M., van Asten S.A., Urbančič-Rovan V., Peters E.J., International Working Group on the Diabetic Foot (IWGDF): Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab. Res. Rev., 2020; 36: e3280
- Małecki R., Rosiński K., Adamiec R.: Etiological factors of infections in diabetic foot syndrome – attempt to define optimal empirical therapy. Adv. Clin. Exp. Med., 2014; 23: 39–48
- Perim M.C., Borges J.C., Celeste S.R., Orsolin E.F., Mendes R.R., Mendes G.O., Ferreira R.L., Carreiro S.C., Pranchevicius M.C.: Aerobic bacterial profile and antibiotic resistance in patients with diabetic foot infections. Rev. Soc. Bras. Med. Trop., 2015; 48: 546–554
- Ramakant P., Verma A.K., Misra R., Prasad K.N., Chand G., Mishra A., Agarwal G., Agarwal A., Mishra S.K.: Changing micro-biological profile of pathogenic bacteria in diabetic foot infections: Time for a rethink on which empirical therapy to choose? Diabetologia, 2011; 54: 58–64
- Robson M.C., Heggers J.P.: Surgical infection. II. The β-hemolytic streptococcus. J. Surg. Res., 1969; 9: 289–292
- Saseedharan S., Sahu M., Chaddha R., Pathrose E., Bal A., Bhalekar P., Sekar P., Krishan P.: Epidemiology of diabetic foot infections in a reference tertiary hospital in India. Braz. J. Microbiol., 2018; 49: 401–406
- Schaper N.C., van Netten J.J., Apelqvist J., Bus S.A., Hinchliffe R.J., Lipsky B.A., IWGDF Editorial Board: Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab. Res. Rev., 2020; 36: e3266
- Schultz G.S., Sibbald R.G., Falanga V., Ayello E.A., Dowsett C., Harding K., Romanelli M., Stacey M.C., Teot L., Vanscheidt W.: Wound bed preparation: A systematic approach to wound management. Wound Repair Regen., 2003; 11: S1–S28
- Singh S.K., Gupta K., Tiwari S., Shahi S.K., Kumar S., Kumar A., Gupta S., Gupta S.K.: Detecting aerobic bacterial diversity in patients with diabetic foot wounds using ERIC-PCR: A preliminary communication. Int. J. Low Extrem. Wounds, 2009; 8: 203–208
- Smith K., Collier A., Townsend E.M., O’Donnel L.E., Bal A.M., Buchter J., Mackay W.G., Ramage G., Williams C.: One step closer to understanding the role of bacteria in diabetic foot ulcers: Char-acterising the microbiome of ulcers. BMC Microbiol., 2016; 16: 54
- Uçkay I., Aragón-Sánchez J., Lew D., Lipsky B.A.: Diabetic foot infections: What have we learned in the last 30 years? Review. Int. J. Infect. Dis., 2015; 40: 81–91
- Yates C., May K., Hale T., Allard B., Rowlings N., Freeman A., Harrison J., McCann J., Wraight P.: Wound chronicity, inpatient care, and chronic kidney disease predispose to MRSA infection in diabetic foot ulcers. Diabetes Care, 2009, 32: 1907–1909
DOI: https://doi.org/10.5604/01.3001.0014.8987 | Journal eISSN: 1732-2693
Language: English
Page range: 362 - 370
Submitted on: May 12, 2020
Accepted on: Feb 2, 2021
Published on: May 25, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Related subjects:
© 2021 Marta Margas, Marta Wróblewska, Halina Marchel, Beata Mrozikiewicz-Rakowska, Piotr Ładyżyński, Ewa Wojciechowska, Leszek Czupryniak, Janusz Krzymień, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.